VHR-IN-2
VHR-IN-2 (Compound SA9) is a selective vaccinia H1-related (VHR) phosphatase inhibitor with an IC50 of 3.1 μM. VHR-IN-2 can be used for the research of cervical cancer[1].
Product Specifications
CAS Number
1146616-14-9
UNSPSC
12352005
Target
Phosphatase
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Cancer
Smiles
CC(C=C1)=CC=C1C2=NN(C3=CC=CC=C3)C=C2/C=C4C(N(C(S/4)=S)CCS(=O)(O)=O)=O
Molecular Formula
C22H19N3O4S3
Molecular Weight
485.60
References & Citations
[1]Wu S, et al. Multidentate small-molecule inhibitors of vaccinia H1-related (VHR) phosphatase decrease proliferation of cervix cancer cells. J Med Chem. 2009 Nov 12;52 (21) :6716-23.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
213493-01 50 µL
SNAP23 (Synaptosomal-associated Protein 23, SNAP-23, SNAP23A, SNAP23B, HsT17016) discontinued
Sign In for Pricing
View Details 213493-02 100 µL
SNAP23 (Synaptosomal-associated Protein 23, SNAP-23, SNAP23A, SNAP23B, HsT17016) discontinued
Sign In for Pricing
View Details 213493-03 200 µL
SNAP23 (Synaptosomal-associated Protein 23, SNAP-23, SNAP23A, SNAP23B, HsT17016) discontinued
Sign In for Pricing
View Details 